While immune thrombocytopenia (ITP) can occur in both adults and children, what makes pediatric ITP most distinct from adult ITP is the high rate of children who improve on their own, noted James ...
Reviewed by Julia M. Cunningham, MD, Assistant Professor, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. Chronic ITP may be an early ...
In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...
“Doptelet represents a significant advancement in the treatment of children and adolescents with persistent or chronic ITP,” said Rachael Grace, MD, MMSc, Pediatric Hematologist and Director, ...
Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results